|
|
||||||||
J Thorac Cardiovasc Surg 2004;127:1226-1227
© 2004 The American Association for Thoracic Surgery
Letter to the editor |
Department of Surgery, University of Illinois at Chicago, Chicago, Ill, USA
| The first 20% of the full text of this article appears below. |
To the Editor:
I read with interest the article by Habib and associates1 in the June issue of the Journal concerning the role of the lowest hematocrit as the predictor variable on early and late postoperative outcomes. It is important to maintain the hematocrit within the normal range and avoid extremes. The mere effect of such a strong association begs for a prospective randomized study, as stated by the authors. However, their discussion and conclusion based on the large number of retrospective patients are incomplete. In the field of cardiovascular epidemiology, anemia occurs in 15% to 55% of patients with chronic heart failure.2 However, it is unknown whether a strong association of anemia and heart
Related Article
J. Thorac. Cardiovasc. Surg. 2004 127: 1227-1228.
This article has been cited by other articles:
![]() |
R. A. Jonas Hematocrit trial J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1200 - 1200. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |